Apotheek Devos
ActiveSummary
The annual accounts of Apotheek Devos for financial year 2025 show a net loss of 64% of the equity at the start of that year. The 2025 annual accounts show equity of €13,338 and a net result of -€24,132. Equity is shrinking by about 12% per year across the filed financial years. Its solvency ranks better than 14% of 5,017 sector peers (NACE 47, financial year 2025). The company has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.8% (low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Apotheek Devos
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaamse Gewest en/of Brussels Gewest, gevestigd door besluit van bestuurder” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “BEVOEGDHEID VAN DE BESTUURDERS: Als er slechts één bestuurder is, is het geheel van de bevoegdheden van de bestuurders aan hem toegekend…”
- Board ruleHow the board is made up, meets and takes decisions.
- “Een of meer, natuurlijke personen of rechtspersonen al dan niet aandeelhouder” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Saturday of May at 10:00